Last edition
News about "Cancer Diagnostics"
Hikma Welcomes FDA Approval of Guardant360 Liquid CDx, Expanding Precision Cancer Diagnostics
The FDA-approved Guardant360 Liquid CDx enables advanced cancer biomarker testing through a simple blood draw, supporting faster and more precise treatment decisions.
Cancer Diagnostics | 25/06/2026 | By News Bureau
Boston Cell Standards Advances Cancer Testing Tools into FDA Qualification Phase
Boston Cell Standards moves closer to standardising cancer diagnostics as its IHC reference tools enter FDA qualification, aiming to improve accuracy and accelerate therapy development.
Cancer Diagnostics | 29/04/2026 | By News Bureau | 119
MedGenome Study Highlights Role of RNA-Based NGS in Improving Sarcoma Diagnosis in India
India’s first prospective study finds that RNA sequencing enhances diagnostic accuracy and influences treatment decisions in complex sarcoma cases, supporting precision oncology in resource-limited settings.
Cancer Diagnostics | 08/04/2026 | By News Bureau
The acquisition marks a significant strategic move for Abbott, enabling the company to expand into high-growth segments of cancer screening and diagnostics.
Cancer Diagnostics | 23/03/2026 | By Darshana | 221
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy